ENTRY       D06626                      Drug
NAME        Onamelatucel-L (USAN);
            Canvaxin (TN)
EFFICACY    Antineoplastic
  TYPE      Cellular therapy product
COMMENT     Treatment of cancer, primarily melanoma
            Specific active immunotherapeutic composed of approximately equal numbers of viable, gamma-irradiated, replication-incompetent whole cells derived from 3 human melanoma cell lines designated as M10-VACC, M24-VACC, and M101-VACC
DBLINKS     PubChem: 47208277
///
